Recce Pharmaceuticals Ltd (RCE) — Capital Reinvestment Ratio

Latest as of June 2014: 3.08x

Recce Pharmaceuticals Ltd (RCE) has a Capital Reinvestment Ratio of 3.08x as of June 2014, meaning it reinvests 3% of its operating cash flow (AU$11.43K) in capital expenditures (AU$35.25K). See Recce Pharmaceuticals Ltd balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

3.08x
Capex / Operating Cash Flow

Operating Cash Flow

AU$11.43K
AUD

Capital Expenditures

AU$35.25K
AUD

Data as of

Jun 2014
Most recent filing

Recce Pharmaceuticals Ltd Capital Reinvestment Ratio (2014–2014)

This chart tracks Recce Pharmaceuticals Ltd's Capital Reinvestment Ratio across 1 annual periods. Check Recce Pharmaceuticals Ltd (RCE) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Recce Pharmaceuticals Ltd (2014–2014)

Year-by-year Capital Reinvestment Ratio for Recce Pharmaceuticals Ltd from 2014 to 2014. For live market cap and broader valuation context, see RCE market cap.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2014 3.08x AU$11.43K AU$35.25K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow